Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Boyce

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
BMC Medical Informatics and Decision Making|April 17, 2015
Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologiesMatthias Samwald, Jose Antonio Miñarro Giménez, Richard D Boyce, et al.
Drug Safety|October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|February 27, 2015
Drug-drug interaction data source survey and linkingSerkan Ayvaz, Qian Zhu, Harry Hochheiser, et al.
Respiratory Care|June 9, 2021
Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System DatabaseHyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, et al.
Scientific Reports|January 13, 2024
Broadening the capture of natural products mentioned in FAERS using fuzzy string-matching and a Siamese neural networkIsrael O Dilán-Pantojas, Tanupat Boonchalermvichien, Sanya B Taneja, et al.
Therapeutic Advances in Drug Safety|June 19, 2023
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance studyBritney A Stottlemyer, Michael C McDermott, Mackenzie R Minogue, et al.
Scientific Reports|May 17, 2022
Machine learning based algorithms to impute PaO<sub>2</sub> from SpO<sub>2</sub> values and development of an online calculatorShuangxia Ren, Jill A Zupetic, Mohammadreza Tabary, et al.
Neurology. Clinical Practice|November 11, 2024
REM Sleep Behavior Disorder Diagnostic Code Accuracy and Implications in the Real-World SettingLana M Chahine, Deena Ratner, Aaron Palmquist, et al.
The Annals of Pharmacotherapy|January 23, 2023
Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)Ainhoa Gómez-Lumbreras, Richard D Boyce, Lorenzo Villa-Zapata, et al.
Journal of Integrative and Complementary Medicine|June 11, 2026
A Retrospective Pharmacovigilance Disproportionality Analysis of Possible Nephrotoxicity and Natural Products Using Data from the FDA Adverse Event Reporting SystemCaiden J Lukan, Iman Karimzadeh, Tiffany L Tran, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
BMC Medical Informatics and Decision Making|April 17, 2015
Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologiesMatthias Samwald, Jose Antonio Miñarro Giménez, Richard D Boyce, et al.
Drug Safety|October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|February 27, 2015
Drug-drug interaction data source survey and linkingSerkan Ayvaz, Qian Zhu, Harry Hochheiser, et al.
Respiratory Care|June 9, 2021
Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System DatabaseHyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, et al.
Scientific Reports|January 13, 2024
Broadening the capture of natural products mentioned in FAERS using fuzzy string-matching and a Siamese neural networkIsrael O Dilán-Pantojas, Tanupat Boonchalermvichien, Sanya B Taneja, et al.
Therapeutic Advances in Drug Safety|June 19, 2023
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance studyBritney A Stottlemyer, Michael C McDermott, Mackenzie R Minogue, et al.
Scientific Reports|May 17, 2022
Machine learning based algorithms to impute PaO<sub>2</sub> from SpO<sub>2</sub> values and development of an online calculatorShuangxia Ren, Jill A Zupetic, Mohammadreza Tabary, et al.
Neurology. Clinical Practice|November 11, 2024
REM Sleep Behavior Disorder Diagnostic Code Accuracy and Implications in the Real-World SettingLana M Chahine, Deena Ratner, Aaron Palmquist, et al.
The Annals of Pharmacotherapy|January 23, 2023
Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)Ainhoa Gómez-Lumbreras, Richard D Boyce, Lorenzo Villa-Zapata, et al.
Journal of Integrative and Complementary Medicine|June 11, 2026
A Retrospective Pharmacovigilance Disproportionality Analysis of Possible Nephrotoxicity and Natural Products Using Data from the FDA Adverse Event Reporting SystemCaiden J Lukan, Iman Karimzadeh, Tiffany L Tran, et al.
Pageof 10